J. JasonWilliams

Of Counsel

Atlanta + 1.404.581.8286

Jason Williams practices patent, trademark, and trade secret law, with a primary focus on IP litigation for industries such as biopharma. His experience includes patent litigation in federal district courts, the PTAB, and the International Trade Commission (ITC) on a wide range of technologies, including wireless and satellite telecommunications, industrial and commercial products, software, security systems, pharmaceuticals, and business methods. He also has extensive experience in trademark, false advertising, and unfair competition litigation in federal district courts, as well as self-regulatory proceedings before the National Advertising Division of the Council of Better Business Bureaus (NAD).

Jason's experience covers all stages of patent and trademark litigation, including pleading, discovery, motion practice, Markman, settlement negotiation, trial preparation, and trial. His experience also includes noninfringement analyses, reexaminations and inter partes review of patents (IPR), and counseling clients regarding patent, trademark, and copyright protection and enforcement.

Prior to attending law school, Jason spent three years conducting biomedical research at the University of Louisville's Department of Medicine in the nephrology and cardiology divisions.

Jason is active in several professional and community service organizations, including the Litigation Committee of the IP Section of the Atlanta Bar Association, the American Bar Association Section of Intellectual Property, and Jerusalem House.


  • R.J. Reynolds successfully enforces patents in ITC trial against Philip Morris in dispute over cigarette alternativeJones Day's client Reynolds achieved a precedent-setting victory before the International Trade Commission (ITC) against its main competitors Philip Morris Products S.A. ("Philip Morris") and Altria Client Services LLC ("Altria") in a patent infringement dispute involving tobacco heating and vaping products.
  • Takeda trial win in Hatch-Waxman case involving diabetes products upheld by Federal CircuitJones Day successfully represented Takeda Pharmaceutical Company Ltd. in a Hatch-Waxman Act dispute against companies seeking to market generic versions of three diabetes products prior to the expiration of Takeda's patents.
  • Specialty engineered woods manufacturer reaches settlement in trade secret and supply agreement disputeJones Day represented an industry leader in the manufacture of specialty engineered wood products in a lawsuit against a supplier involving allegations of misappropriation of trade secrets, breach of contract, tortious interference, and unfair competition.
  • Global chemical company protects trade secrets, obtains judgment, damages, and attorneys' fees against former employeeJones Day assisted a global chemical company in pursuing claims of trade secret misappropriation and violations of the Computer Fraud and Abuse Act ("CFAA") against a former employee when the company discovered the employee had been systematically downloading decades of its trade secrets and confidential information.
  • Celgene acquired by Bristol-Myers Squibb for approximately $74 billionJones Day advised Celgene Corporation (NASDAQ: CELG) in connection with the intellectual property and technology transactions aspects of its cash-and-stock merger with Bristol-Myers Squibb (NYSE: BMY) which has an equity value of approximately $74 billion.
  • Cooper Lighting successfully asserts patents relating to LED downlights against competitorsJones Day represented Eaton Corporation's subsidiary Cooper Lighting, LLC, in successfully asserting four Cooper Lighting patents on LED downlights against competitors Cordelia Lighting, Inc. and Jimway, Inc.
  • AbbVie defeats IPR petition filed by Coherus challenging Humira®Jones Day successfully defended AbbVie Inc. in connection with an IPR petition brought by Coherus Biosciences, Inc. against U.S. Patent No. 9,114,166, which is directed to formulations for AbbVie's antibody therapeutic Humira®.
  • AbbVie successfully defends patents related to HUMIRA® against IPR petitions filed by AmgenJones Day served as co-counsel in the successful defense of AbbVie Inc. in two IPRs brought by Amgen in connection with U.S. Patent Nos. 8,916,157 and 8,916,158 related to AbbVie's blockbuster antibody therapeutic, HUMIRA®.
  • Motorola Mobility resolves patent infringement case after obtaining companion IPR institutionAfter Rothschild Storage Retrieval Innovations, LLC ("RSRI") filed a patent infringement case against Motorola Mobility LLC in the United States District Court for the Southern District of Florida, Jones Day filed an IPR petition on behalf of Google Inc. and Motorola Mobility challenging the validity of U.S. Patent No. 8,437,797.
  • Aimetis Corp. settles DJ action regarding video surveillance patentJones Day represented Aimetis Corp. in a declaration judgment action relating to Hawk Technology Systems, LLC's U.S. Reissue Patent No. RE43,462, which is directed to video monitoring technology, and specifically to varying video streaming and image size in different windows on the same monitor.
  • Celgene defends REMS patents against Kyle Bass' IPR petitionsJones Day is representing Celgene Corporation in defending four IPR petitions filed by Coalition for Affordable Drugs VI LLC - a company formed by hedge fund manager Kyle Bass - against U.S. Patent Nos. 6,045,501 and 6,315,720, which are listed in the Orange Book for Celgene's REVLIMID®, POMALYST®, and THALOMID® brand drugs, and which pertain to Celgene's Risk Evaluation and Mitigation Strategy (REMS)™ for those drugs.
  • March Networks settles DJ action regarding video surveillance patentJones Day represented March Networks Corporation in a declaration judgment action relating to Hawk Technology Systems, LLC's U.S. Reissue Patent No. RE43,462, which is directed to video monitoring technology, and specifically to varying video streaming and image size in different windows on the same monitor.
  • Genetec files declaratory judgment action against Hawk Technology Systems, LLCJones Day represented Genetec, Inc. in an action seeking a declaration that it did not infringe, and had intervening rights in, Hawk Technology Systems, LLC's U.S. Reissue Patent No. RE 43,462, claiming to cover video storage and display technology.
  • DIRECTV distributors prevail on summary judgment to successfully fend off patent infringement claims brought by Global Communications involving distribution of satellite signalsJones Day represented four DIRECTV distributors in a patent infringement action related to the distribution of satellite TV signals.
  • Exide Technologies files declaratory judgment action against Johnson Controls Battery GroupJones Day represented Exide Technologies in an action seeking a declaration that Exide's manufacture and sale of a new spiral wound battery product did not violate the defendant's alleged trademark or trade dress rights.
  • Tupperware resolves patent infringement case related to websites, marketing and inventory systemJones Day represented Tupperware in the successful resolution of a patent infringement action charging that Tupperware websites, marketing and inventory system infringed a patent entitled "Computerized Sales Force Automation System."
  • Schütz Container Systems successfully resolves patent infringement and trademark action against National Container Group and Mauser Corporation regarding marketing and sale of intermediate bulk containersJones Day represented Schütz Container Systems in a patent infringement and trademark lawsuit regarding the sale of reconditioned intermediate bulk containers (IBCs) with non-Schütz inner containers.
  • CenterPoint Energy Resources successfully defends against Superfund claims involving former manufactured gas plant facility in Bangor, MaineJones Day is representing CenterPoint Energy Resources Corp. ("CenterPoint") in defense of a claim brought by Frontier Communications Company for contribution to response costs under the Comprehensive Environmental Response, Compensation and Liability Act ("CERCLA" or "Superfund").
  • KeyCorp, New York Life and RBS entities defend against claims of patent infringement by Phoenix Licensing over system for customized offers in direct marketing program to consumersJones Day represents multiple KeyCorp, New York Life and Royal Bank of Scotland entities in a patent litigation regarding methods and systems for creating customized financial offers in direct marketing communications to consumers.
  • CDC Software defends against claims of patent infringement over sales force automation systemsJones Day represented CDC Software, Inc. and CDC Corporation regarding patent infringement claims involving a software patent which purports to cover sales force automation systems.
  • Speaking Engagements

    • February 26, 2014
      Intellectual Property Protection For Product Designs and Packaging, Jones Day CLE Academy
    • February 10, 2006
      A Primer on Intellectual Property for the General Practitioner, The Tennessee Valley Public Power Association's Annual Legal Seminar